These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 18701045
1. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells. Han LY, Ye MZ, Li YP, Wang BW, Wang Q, Zhao SH, Li HL. Chin Med J (Engl); 2008 May 05; 121(9):800-5. PubMed ID: 18701045 [Abstract] [Full Text] [Related]
2. Transduction of mesenchymal stem cells with multidrug resistance gene provides protection for bone marrow toxicity after being transplanted into a nude mice model. Han LY, Li YP, Ye MZ, Wang BW, Wang Q, Zhao SH, Li HL. Chin Med J (Engl); 2012 Sep 05; 125(18):3246-50. PubMed ID: 22964317 [Abstract] [Full Text] [Related]
3. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists. Fu J, Chen Z, Cen J, Ruan C. Chin Med J (Engl); 2000 Mar 05; 113(3):228-31. PubMed ID: 11775252 [Abstract] [Full Text] [Related]
6. Chemoprotection effect of multidrug resistance 1 (MDR1) gene transfer to hematopoietic progenitor cells and engrafted in mice with cancer allows intensified chemotherapy. Guo C, Jin X. Cancer Invest; 2006 Nov 05; 24(7):659-68. PubMed ID: 17118775 [Abstract] [Full Text] [Related]
7. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91. Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, Gottesman MM, Tsuruo T. J Gene Med; 2003 May 05; 5(5):366-76. PubMed ID: 12731085 [Abstract] [Full Text] [Related]
8. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Kobayashi H, Takemura Y, Miyachi H. Hum Cell; 2001 Sep 05; 14(3):172-84. PubMed ID: 11774737 [Abstract] [Full Text] [Related]
9. [Chemoprotection of transfer of multidrug resistance gene into human hematopoietic progenitor cell]. Pan L, Tong Y, Zhou S, Wu Y, Mao N, Yang X. Chin Med J (Engl); 2000 Jun 05; 113(6):536-9. PubMed ID: 11775875 [Abstract] [Full Text] [Related]
10. [Transfer and identification of multidrug resistance gene in mesenchymal stem cells derived from human placenta]. Han LY, Li YP, Ye MZ, Wang BW, Wang Q, Zhao SH, Li HL. Zhonghua Yi Xue Za Zhi; 2012 Nov 06; 92(41):2930-3. PubMed ID: 23328244 [Abstract] [Full Text] [Related]
11. The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum deprivation. Bhakta S, Hong P, Koc O. Cardiovasc Revasc Med; 2006 Nov 06; 7(1):19-24. PubMed ID: 16513519 [Abstract] [Full Text] [Related]
12. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Fukuchi Y, Nakajima H, Sugiyama D, Hirose I, Kitamura T, Tsuji K. Stem Cells; 2004 Nov 06; 22(5):649-58. PubMed ID: 15342929 [Abstract] [Full Text] [Related]
13. Construction and characterization of bicistronic retroviral vectors encoding the multidrug transporter and beta-galactosidase or green fluorescent protein. Aran JM, Gottesman MM, Pastan I. Cancer Gene Ther; 1998 Nov 06; 5(4):195-206. PubMed ID: 9694071 [Abstract] [Full Text] [Related]
14. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy. Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T. Clin Cancer Res; 1997 Jun 06; 3(6):947-54. PubMed ID: 9815770 [Abstract] [Full Text] [Related]
15. Therapeutic efficacy and bone marrow protection of the mdr1 gene and over-dose chemotherapy with doxorubicin for rabbits with VX2 hepatocarcinoma. Wang Y, Jin XQ, Wang S, Wang Q, Luo Q, Luo XJ. Hepatobiliary Pancreat Dis Int; 2006 Nov 06; 5(4):545-51. PubMed ID: 17085340 [Abstract] [Full Text] [Related]
16. Chemoprotection effect of retroviral vector encoding multidrug resistance 1 gene to allow intensified chemotherapy in vivo. Guo CB, Li YC, Jin XQ. Cancer Chemother Pharmacol; 2006 Jul 06; 58(1):40-9. PubMed ID: 16284790 [Abstract] [Full Text] [Related]
17. Genetic modification of hematopoietic progenitor cells for combined resistance to 4-hydroperoxycyclophosphamide, vincristine, and daunorubicin. Wang JS, Fang Q, Sun DJ, Chen J, Zhou XL, Lin GW, Lu HZ, Fei J. Acta Pharmacol Sin; 2001 Oct 06; 22(10):949-55. PubMed ID: 11749781 [Abstract] [Full Text] [Related]
18. Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells. Knipper R, Kuehlcke K, Schiedlmeier B, Hildinger M, Lindemann C, Schilz AJ, Fauser AA, Fruehauf S, Zeller WJ, Ostertag W, Eckert HG, Baum C. Gene Ther; 2001 Feb 06; 8(3):239-46. PubMed ID: 11313796 [Abstract] [Full Text] [Related]
19. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site]. Fu J, Chen Z, Wang W. Zhonghua Xue Ye Xue Za Zhi; 1998 Dec 06; 19(12):619-22. PubMed ID: 11263327 [Abstract] [Full Text] [Related]
20. Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivo. Buss EC, Laufs S, Naundorf S, Kuehlcke K, Nagy KZ, Zeller WJ, Fruehauf S. Cytotherapy; 2006 Dec 06; 8(6):562-9. PubMed ID: 17148033 [Abstract] [Full Text] [Related] Page: [Next] [New Search]